Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiling Zhao

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Blood Advances|June 17, 2025
IGSF9-targeted therapy inhibits the progression of acute myeloid leukemiaLijun Hui, Jing Xiao, Zhiling Zhao, et al.
Cell Transplantation|November 30, 2022
Therapeutic Efficacy of Human Mesenchymal Stem Cells With Different Delivery Route and Dosages in Rat Models of Spinal Cord InjuryGuangyang Liu, Zhiling Zhao, Herui Wang, et al.
Cancer Research|July 28, 2023
Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti-PD-1 ImmunotherapyYifan Liu, Hongying Wang, Xinyu Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 2, 2024
LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathwayHongying Wang, Lei Wang, Huiwen Luan, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Blood Advances|June 17, 2025
IGSF9-targeted therapy inhibits the progression of acute myeloid leukemiaLijun Hui, Jing Xiao, Zhiling Zhao, et al.
Cell Transplantation|November 30, 2022
Therapeutic Efficacy of Human Mesenchymal Stem Cells With Different Delivery Route and Dosages in Rat Models of Spinal Cord InjuryGuangyang Liu, Zhiling Zhao, Herui Wang, et al.
Cancer Research|July 28, 2023
Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti-PD-1 ImmunotherapyYifan Liu, Hongying Wang, Xinyu Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 2, 2024
LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathwayHongying Wang, Lei Wang, Huiwen Luan, et al.
Pageof 8